SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-000393
Filing Date
2023-01-04
Accepted
2023-01-04 18:00:58
Documents
1
Period of Report
2023-01-03

Document Format Files

Seq Description Document Type Size
1 form4-01042023_110131.html 4  
1 form4-01042023_110131.xml 4 7101
  Complete submission text file 0001415889-23-000393.txt   8653
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Issuer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121
Business Address
Snyder Mark Howard (Reporting) CIK: 0001902866 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32335 | Film No.: 23508559